OncologyA checkpoint combination extends survival in advanced melanoma
Five-year data suggest durable responses for a third of patients, but toxicity remains the trade-off.
Clara Whitfield · 1 November 2026
Tag
Immunotherapy
OncologyOncologyClinical trials, drug development and research news
Tag
OncologyFive-year data suggest durable responses for a third of patients, but toxicity remains the trade-off.
Clara Whitfield · 1 November 2026